The current executive team at DBV Technologies has a history of working in the biotech industry and holds degrees in biochemistry and mathematics from the Université de Montréal. They have experience as CEO's, Chairman's, and Non Executive Directors at companies such as Alcresta Therapeutics, Indivior, Regenxbio, Bellerophon Therapeutics, and IKARIA.
View all